AHR — Stock Film
STOCK FILMSCENE 1/11AHR · $52.16
Stock Expert AI presents
AHR
American Healthcare REIT, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
American Healthcare REIT, Inc. A quick introduction.

On the stock market since 2024, it operates in the world of real estate. It has 114 employees. Now — the numbers.

on the stock market since 2024
114 employees
$9.8B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $3 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 3%

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 16% a year over the last 4 years. Red columns mark years that ended in a loss.

$1.3B
2021
$1.6B
2022
$1.9B
2023
$2.1B
2024
$2.3B
2025
Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $1.6B. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
37
weak

Clearly below the class average.

FINANCIAL STRENGTH
97
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
33
very weak

Clearly below the class average.

GROWTH
29
very weak

Clearly below the class average.

PRICE MOMENTUM
85
very strong

The stock has been running stronger than the market lately.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Thin profit on each sale3/10
Costs eat into the margin4/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 10% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
Analysts’ target sits above today’s price

The average analyst price target is $60.0015% above today’s price.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $1.00 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
A rich price tag

The company’s market value is 140 times its annual profit. Even a small disappointment could hit the price hard.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 29/100.

3
THE RISKS · 3/3
The price runs ahead of the earnings

Today’s price already includes part of tomorrow’s optimism. Report-card grade: 33/100.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, AHR sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: AHR is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

Analysts’ average target sits above today’s price, yet the valuation grade (33/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film